sorafenib has been researched along with Leg Dermatoses in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yao, CA | 1 |
| Carriere, C; Eisendle, K; Kluge, R; Mazzoleni, G; Pichler, M | 1 |
2 other study(ies) available for sorafenib and Leg Dermatoses
| Article | Year |
|---|---|
Sorafenib-induced erythema annulare centrifugum with spontaneous resolution after skin biopsy.
Topics: Aged; Biopsy, Needle; Carcinoma, Hepatocellular; Erythema; Humans; Immunohistochemistry; Leg Dermatoses; Liver Neoplasms; Male; Remission, Spontaneous; Skin Diseases, Genetic; Sorafenib | 2018 |
Acne inversa-like lesions associated with the multi-kinase inhibitor sorafenib.
Topics: Aged; Antineoplastic Agents; Drug Eruptions; Hidradenitis Suppurativa; Humans; Leg Dermatoses; Male; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Sorafenib | 2014 |